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Abstract
Int roduction: The contamination of serum or lithium heparin blood with ethylenediaminetetraacetic acid (EDTA) salts may affect accuracy of some 
critical analytes and jeopardize patient safety. The aim of this study was to evaluate the effect of lithium heparin sample contamination with diffe-
rent amounts of K2EDTA.
Materials and methods: Fifteen volunteers were enrolled among the laboratory staff. Two lithium heparin tubes and one K2EDTA tube were col-
lected from each subject. The lithium-heparin tubes of each subject were pooled and divided in 5 aliquots. The whole blood of K2EDTA tube was then 
added in scalar amount to autologous heparinised aliquots, to obtained different degrees of K2EDTA blood volume contamination (0%; 5%; 13%; 
29%; 43%). The following clinical chemistry parameters were then measured in centrifuged aliquots: alanine aminotranspherase (ALT), bilirubin 
(total), calcium, chloride, creatinine, iron, lactate dehydrogenase (LD), lipase, magnesium, phosphate, potassium, sodium.
Results: A significant variation starting from 5% K2EDTA contamination was observed for calcium, chloride, iron, LD, magnesium (all decreased) 
and potassium (increased). The variation of phosphate and sodium (both increased) was significant after 13% and 29% K2EDTA contamination, res-
pectively. The values of ALT, bilirubin, creatinine and lipase remained unchanged up to 43% K2EDTA contamination. When variations were compared 
with desirable quality specifications, the bias was significant for calcium, chloride, LD, magnesium and potassium (from 5% K2EDTA contamination), 
sodium, phosphate and iron (from 29% K2EDTA contamination).
Conclusions: The concentration of calcium, magnesium, potassium, chloride and LD appears to be dramatically biased by even modest K2EDTA con-
tamination (i.e., 5%). The values of iron, phosphate, and sodium are still reliable up to 29% K2EDTA contamination, whereas ALT, bilirubin, creatinine 
and lipase appear overall less vulnerable towards K2EDTA contamination.
Key words: contamination; EDTA; patient safety; preanalytical variability; total quality management; preanalytical phase
Received: July 04, 2014 Accepted: August 23, 2014
Contamination of lithium heparin blood by K2-ethylenediaminetetraacetic acid 
(EDTA): an experimental evaluation
Gabriel Lima-Oliveira*1,2, Gian Luca Salvagno1, Elisa Danese1, Giorgio Brocco1, Gian Cesare Guidi1,2, Giuseppe Lippi3
1Laboratory of Clinical Biochemistry, Department of Life and Reproduction Sciences, University of Verona, Verona, Italy
2Post-Graduate Program of Pharmaceutical Sciences, Department of Clinical Analyses, Federal University of Parana, Curitiba, Parana, 
Brazil




The ethylenediaminetetraacetic acid (EDTA) salts 
are anticoagulants widely used in laboratory diag-
nostics, especially for hematological testing and 
for stabilizing the blood for assessment of unsta-
ble and fragile molecules such as cytokines, pep-
tides and cardiac biomarkers (1). The leading prin-
ciple underlining the use of EDTA as an anticoagu-
lant relies on its ability to irreversibly sequester 
(i.e., chelate) divalent ions such as magnesium, 
manganese, zinc and calcium, with the last ion ex-
erting an irreplaceable function in the physiologi-
cal process of blood coagulation (1). This favoura-
ble property may turn out to be a challenge under 
some circumstances, especially when serum or 
plasma used for analysis of a number of clinical 
chemistry and coagulation tests are inadvertently 
contaminated by this additive. On this assumption, 
the Clinical Laboratory Standards Institute (CLSI) 
currently encourages the use of a specific “order of 
draw” when collecting blood specimens, which 
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specifically entails the collection of EDTA-contain-
ing tubes at the end of the sequence (2). This rec-
ommendation is essentially based on anecdotal 
evidence, as well as on a series of outdated case 
reports which described substantial bias of calci-
um and potassium after cross-contamination of 
potassium (K)2-EDTA or K3-EDTA between tubes 
collected for haematological testing and the fol-
lowing serum tubes (3,4). In another article, we re-
ported the occurrence of spurious hyperkalemia 
and hypocalcemia due to inadequate phlebotomy 
procedure, that led to K2EDTA contamination from 
a blood tube and a needleless blood gas dedicat-
ed-syringe containing 80 I.U. lithium heparin (5). 
This evidence has been convincingly contradicted 
by data reported in recent studies, showing that 
results of coagulation tests and of those clinical 
chemistry parameters that are more vulnerable by 
cross-contamination of ion-chelating additives 
(i.e., potassium, sodium, calcium, magnesium and 
phosphate) are not significantly biased by a casual 
order of draw (6-10).
Regardless of whether or not a casual order of 
drawing blood tubes should be regarded as a real 
problem or a myth, it is unquestionable that the 
contamination of serum or lithium heparin blood 
with EDTA salts dramatically impairs the quality of 
testing and, when unrecognised, may jeopardize 
patient safety and waste healthcare resources. The 
major problem of EDTA contamination in diagnos-
tic testing emerges from a direct chelating effect 
on divalent ions, as well as from the potential in-
troduction of potassium (and sodium, to a lesser 
extent) contained in the EDTA salts (1). It is also 
noteworthy that EDTA contamination seems to oc-
cur more frequently than conventionally assumed 
in routine laboratory practice. A recent study re-
ported that EDTA-contaminated samples were the 
cause of 14.3% cases of hypocalcaemia, 4.8% cases 
of hypomagnesaemia, 3.1% of hyperkalemia and 
1.4% cases of hypozincaemia (11). The major sourc-
es of serum or plasma contamination by EDTA 
were then identified as backflow when collecting 
blood using evacuated tube systems, decanting of 
blood from EDTA containing tubes, and droplet 
transfer of EDTA blood via a syringe tip (11).
The effect of EDTA salts contamination on clinical 
chemistry testing has been reported in some epi-
demiological investigations (11,12), but it has not 
been precisely estimated in an experimental study. 
As such, the aim of this investigation was to evalu-
ate the effect of lithium heparin sample contami-
nation with different amounts of K2EDTA blood, by 
assessing a panel inclusive of the most frequently 




The study population consisted in 15 volunteers 
(mean age 48 years, range 33–60 years; 5 males 
and 10 females), enrolled among the laboratory 
staff (i.e., 74 subjects). Blood samples were collect-
ed at rest, after an overnight fast, between 8 and 9 
AM by a single and experienced phlebotomist and 
following the CLSI H03-A6 document with minor 
modifications (13). Each patient provided an in-
formed consent for being enrolled in this study, 
which was in accord with the ethical standards es-
tablished by the institution in which the experi-
ments were performed and the Helsinki Declara-
tion of 1975.
Study design
According to our experimental design, 3 sequen-
tial blood tubes (Becton Dickinson Italia, Milan, Ita-
ly) were collected from each volunteer, as follows:
Two lithium-heparin blood tubes tube without •	
gel (13 x 110 mm, 6.0 mL BD Vacutainer® plastic 
whole blood tube without gel containing lithi-
um-heparin 102 I.U.; Ref. 368886).
One K•	 2EDTA blood tube (13 x 75 mm, 3.0 mL BD 
Vacutainer® plastic whole blood tube contain-
ing 3.4 mg of spray-coated K2EDTA; Ref. 367835).
All blood tubes were filled up to the nominal vol-
ume, and all phases of sample collection were ac-
curately standardized. The two lithium-heparin 
tubes of each subject were pooled to obtain 12 mL 
of heparinised blood, which was then divided in 5 
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aliquots of 2 mL each. The whole blood of the 
K2EDTA tube was then added in scalar amount to 
the autologous heparinized aliquots, to obtain dif-
ferent degrees of K2EDTA blood volume contami-
nation (Table 1). The aliquots were then mixed by 
gentle inversion and centrifuged at 1300 x g for 10 
min at room temperature. The following clinical 
chemistry parameters were then measured in all 
aliquots using the same Roche cobas 6000 c501 
(Roche Diagnostics GmbH, Mannheim, Germany): 
alanine aminotranspherase (ALT), bilirubin (total), 
calcium, chloride, creatinine, iron, lactate dehydro-
genase (LD), lipase, magnesium, phosphate, potas-
sium and sodium. All parameters were measured 
in one single analytical run according to manufac-
turer’s specifications and using proprietary re-
agents with the same lot number. The analyzer 
was also previously calibrated against appropriate 
proprietary reference standard material and veri-
fied by means of third-party internal quality con-
trol.
Statistical analysis
The significance of difference between the refer-
ence uncontaminated aliquots and those contain-
ing different degrees of K2EDTA contamination 
was evaluated with Wilcoxon’s matched pairs test. 
The mean (percentage) bias was also assessed with 
Bland and Altman plots, and then compared to the 
desirable quality specifications for bias provided 
by Ricos et al. (14). The concentration of the differ-
ent parameters was reported as mean ± standard 
deviation (SD), whereas the bias was calculated as 
mean and 95% confidence interval (95% CI). The 
level of statistical significance was set at P < 0.05.
Results
The main results of this study are shown in table 2 
and figure 1. A statistically significant variation 
starting from 5% K2EDTA contamination was ob-
served for calcium, chloride, iron, LD, magnesium 
(all decreased) and potassium (increased). The var-
iation of phosphate and sodium (both increased) 
became statistically significant with 13% and 29% 
K2EDTA contamination, respectively. The values of 
ALT, bilirubin, creatinine and lipase remained un-
changed up to 43% K2EDTA contamination. When 
the variation was compared with the desirable 
quality specifications, the bias appeared to be sig-
nificant for calcium, chloride, LD, magnesium and 
potassium (starting from 5% K2EDTA contamina-
tion), sodium, phosphate and iron (starting from 
29% K2EDTA contamination) (Figure 1).
Discussion
The results of our experimental investigation pro-
vide a precise bias estimation of K2EDTA blood vol-
ume contamination when performing a large pan-
el of clinical chemistry tests. The dramatic bias in 
the measured concentration of calcium, magnesi-
um and potassium (Figure 1) occurring after a very 
modest K2EDTA contamination (i.e., < 5%) provides 
additional evidence in support of the need to im-
plement reliable phlebotomy guidelines, along 
with developing specific training programs for 
healthcare phlebotomy staff aimed at reducing 
preanalytical errors (15-18). We also observed that 
the concentration of phosphate and sodium was 
affected, but the bias became clinically significant 
over 13% K2EDTA blood volume contamination. 
Table 1. Volumes used to obtain different degrees of K2EDTA blood volume contamination.
K2EDTA contamination (mg/dL)
Aulogous blood with 0.00 0.09 0.24 0.51 0.77
litium heparin 2 mL 2 mL 2 mL 2 mL 2 mL
K2EDTA* – 0.1 mL (5%) 0.3 mL (13%) 0.8 mL (29%) 1.5 mL (43%)
Legend: * percentage values regard the proportionality of autologous blood (volume/volume). We have estimated EDTA 
concentration from the preceding EDTA-containing tube. It was predicted taking into account that a mass concentration of 1.8 mg 
of K2EDTA per 1 mL of blood as declared by BD®.
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Figure 1. Effect of different degree of lithium heparin with K2-ethylenediaminetetraacetic acid (EDTA) blood volume contamination 
on alanine aminotranspherase (ALT), bilirubin (total), calcium, chloride, creatinine, iron, lactate dehydrogenase (LD), lipase, magne-
sium, phosphate, potassium and sodium. The percentage bias is shown as mean and 95% confidence interval (95% CI). The dotted 
lines delimit the desirable quality specifications for bias.
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The different bias observed on each analyte prob-
ably mirrors the different attraction-force degrees 
between chelating agent (i.e., EDTA) and metal 
ions (i.e. Ca++, Mg++, Fe+++) (19). Briefly, chelation 
entails the generation of two or more separate co-
ordinate bonds between a polydentate (multiple 
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bonded) ligand and a single central atom. It is also 
noteworthy that the EDTA salts have different de-
grees of ionization (20). In our study we used vacu-
um tubes containing dipotassium EDTA (K2EDTA) 
formally known as 2-({2-[bis (carboxylatomethyl)
azaniumyl]ethyl}(carboxylatomethyl)azaniumyl)-
acetate dihydrate, 2K+ · C10H14N2O82- · 2H2O. From a 
genuine chemistry perspective, whole blood is 
composed of an aqueous liquid (i.e., plasma), in 
which corpuscular elements (i.e., blood cells and 
platelets) are suspended. In whole blood, K2EDTA 
dissociates in two K+ plus one C10H14N2O82-. Conse-
quently, this free carboxylic acid form strongly 
chelates divalent metal ion (i.e. Ca++ and Mg++) but 
less powerfully interacts with transition metal ions 
such as Fe+++ (19). Additional, nonmetal elements 
such as Cl- and P3-, which are incapable of forming 
simple positive ions in solution, do not interact 
with EDTA. Phosphorus is measured from phos-
phate (PO43−) on Roche cobas 6000 c501 (Roche 
Diagnostics GmbH, Mannheim, Germany) (21). As 
such, our data (Table 2 and Figure 1) seems in 
agreement with the aforementioned theory. The 
statistically significance observed for Cl-, PO43−, 
and Na+ probably reflects both situations: i) osmo-
ses effect as a result of K+ dissociation from K2ED-
TA; ii) generation of sub products (i.e. KCl, NaOH, 
H3PO4, PO4Na3) after both Ca++, Mg++ and Fe+++ 
chelation process. This would finally explain why 
the significant variation observed for Cl-, PO43−, 
and Na+ is not directly correlated with the EDTA 
chelating force.
The identification of serum or lithium heparin sam-
ple contamination by EDTA salts is often challeng-
ing and may seriously jeopardize both the clinical 
decision-making and patient safety. The presence 
of K2EDTA or K3EDTA in serum or plasma speci-
mens may mask true cases of hypokalaemia or hy-
percalcaemia, whereas true cases of hypokalaemia 
may be misjudged as significant hyperkalaemias 
(12). Hyperkalemia is a medical emergency requir-
ing urgent intervention to prevent unfavourable 
outcomes, which are mainly represented by per-
turbations of cardiac rhythm (22). It is hence im-
portant that potential causes of spurious potassi-
um elevation are ruled out, to prevent the admin-
istration of potassium-lowering therapy in other-
wise hypokalaemic or normokalaemic subjects. 
Similar conclusions can be drawn for spurious de-
creases of calcium and magnesium, which may 
also trigger unjustified panic and inappropriate 
treatment (23). According to this evidence, the se-
rial measurement of EDTA in hyperkalaemic, hy-
pocalcaemic and hypomagnesaemic samples in 
order to exclude EDTA salts contamination may be 
regarded as another potential strategy for safe-
guarding patient safety, since serum EDTA assays 
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EDTA contamination
Desirable 
bias 0% 5% 13% 29% 43%
ALT
Values (U/L) 20.0 ± 6.5 20.2 ± 6.5 20.3 ± 6.7 20.1 ± 6.8 20.3 ± 6.7
Bias (%)  ± 11.5% - 1% (-2 to 5%) 1% (-2 to 4%) 0% (-2 to 2%) 1% (0 to 3%)
P-value - 0.510 0.334 0.320 0.104
Bilirubin (total)
Values (µmol/L) 8.5 ± 4.2 8.6 ± 4.2 8.5 ± 4.3 8.6 ± 4.3 8.5 ± 4.2
Bias (%)  ± 8.9% - 1% (-2 to 3%) -1% (-4 to 3%) 0% (-2 to 3%) -1% (-5 to 2%)
P-value - 0.470 0.818 0.474 0.702
Calcium
Values (mmol/L) 2.4 ± 0.1 2.1 ± 0.1 1.6 ± 0.1 0.6 ± 0.1 0 ± 0
Bias (%)  ± 0.8% - -12% (-11 to -13%) -33% (-32 to -35%) -75% (-72 to -77%) -100%
P-value - < 0.001 < 0.001 < 0.001 < 0.001
Chloride
Values (mmol/L) 103.2 ± 1.8 102.1 ± 1.5 101.3 ± 1.6 99.8 ± 1.6 98.9 ± 1.7
Bias (%)  ± 0.5% - -1.0 (-0.7 to -1.4%) -1.8% (-1.3 to -2.2%) -3.2% (-2.9 to -3.5%) -4.2% (-3.7 to -4.6%)
P-value - < 0.001 < 0.001 < 0.001 < 0.001
Creatinine
Values (µmol/L) 69.2 ± 12.2 69.3 ± 11.9 68.7 ± 12.1 68.8 ± 12.0 69.7 ± 12.5
Bias (%)  ± 4.0% - 0% (-2 to 2%) 0% (-3 to 2%) 0% (-3 to 2%) -1% (-2 to 4%)
P-value - 0.918 0.601 0.683 0.662
Iron
Values (µmol/L) 17.2 ± 6.7 16.7 ± 6.5 16.3 ± 6.4 15.5 ± 6.2 14.8 ± 5.8
Bias (%)  ± 8.8% - -3% (-1 to -5%) -5% (-3 to -8%) -10% (-8 to -13%) -14% (-12 to -17%)
P-value - 0.004 < 0.001 < 0.001 < 0.001
LD
Values (U/L) 646 ± 120 541 ± 84 503 ± 84 478 ± 71 437 ± 50
Bias (%)  ± 4.3% - -14% (-7 to -22%) -20% (-13 to -27%) -24% (-18 to -31%) -31% (-25 to -36%)
P-value - 0.003 0.003 0.001 < 0.001
Lipase
Values (U/L) 36.9 ± 20.5 36.5 ± 20.7 36.3 ± 20.7 36.5 ± 21.1 36.6 ± 21.1
Bias (%)  ± 11.3% - -1% (-3 to 1%) -2% (-4 to 0%) -2% (-4 to 1%) -1% (-4 to 2%)
P-value - 0.353 0.135 0.403 0.597
Magnesium
Values (mmol/L) 0.8 ± 0.1 0.6 ± 0.1 0.4 ± 0.1 0.1 ± 0.1 0 ± 0
Bias (%)  ± 1.8% - -23% (-22 to -24%) -55% (-53 to -56%) -84% (-83 to -85%) -94% (-94 to -96%)
P-value - < 0.001 < 0.001 < 0.001 < 0.001
Table 2. Effect of different degree of lithium heparin blood contamination by K2-ethylenediaminetetraacetic acid (EDTA) on alanine 
aminotranspherase (ALT), bilirubin (total), calcium, chloride, creatinine, iron, lactate dehydrogenase (LD), lipase, magnesium, phos-
phate, potassium and sodium.
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Phosphate
Values (mmol/L) 0.9 ± 0.3 0.9 ± 0.3 1.0 ± 0.3 1.0 ± 0.3 1.0 ± 0.3
Bias (%)  ± 3.4% - 1% (0 to 2%) 3% (2 to 4%) 7% (5 to 9%) 9% (6 to 12%)
P-value - 0.217 < 0.001 < 0.001 < 0.001
Potassium
Values (mmol/L) 4.3 ± 0.4 4.9 ± 0.4 6.2 ± 0.5 9.1 ± 0.6 11.7 ± 0.8
Bias (%)  ± 4.8% - 15% (13 to 18%) 47% (44 to 50%) 114% (108 to 120%) 175% (168 to 183%)
P-value - < 0.001 < 0.001 < 0.001 < 0.001
Sodium
Values (mmol/L) 139.9 ± 1.9 139.9 ± 1.7 140.0 ± 1.5 140.7 ± 1.8 140.9 ± 1.7
Bias (%)  ± 0.2% - 0% (-0.4 to 0.4%) 0.1% (-0.4 to 0.5%) 0.5% (0.1 to 0.9%) 0.7% (0.2 to 1.2%)
P-value - 1.000 0.843 0.028 0.013
P-values were compared to the uncontaminated aliquots. The concentration of the different parameters is shown as mean ± 
standard deviation, whereas the percentage bias is presented as mean and 95% confidence interval (95% CI).
Some previous epidemiological studies investigat-
ed the effect of EDTA salts contamination on dif-
ferent panels of laboratory tests. Davidson as-
sessed a large number of lithium heparin speci-
mens received from inpatients, outpatients, and 
general practices throughout the local area (12), 
and reported that the analytes mostly biased by 
the presence of K3EDTA were calcium (-100%), 
magnesium (-100%) and unsaturated iron-binding 
capacity (+335%). Additional effects could be ap-
preciated for bicarbonate (-17%), LD (-14%), creat-
ine kinase (CK; -61%), amylase (-34.3%) and alkaline 
phosphatase (ALP; -70.5%). Both aspartate ami-
notranspherase (AST) and ALT were virtually unaf-
fected by EDTA contamination. In a subsequent 
study, Sharratt et al. analyzed the potential K-EDTA 
contamination (it was not specified whether K2 or 
K3 were used) in as many as 12,895 serum samples 
(11), and found that the concentration of EDTA was 
negatively correlated with that of calcium (r = 
0.673; P < 0.001), zinc (r = 0.424; P = 0.017) and mag-
nesium (r = 0.551; P = 0.001), while it was positively 
associated with that of potassium (r = 0.554; P = 
0.001). In agreement with the epidemiological data 
of Davidson (12), we failed to find substantial varia-
tions of ALT, as well as of bilirubin, creatinine, lipase 
up to 43% K2EDTA contamination. This is notewor-
thy because, despite it is widely accepted that un-
suitable samples (24,25), including those contami-
nated by external fluids or additives (26), should 
not be analyzed and results suppressed, the varia-
tions observed in these four common parameters 
remained clinically acceptable, so that the single 
laboratory may decided whether test results in 
samples with as much as 43% of K2EDTA contami-
nation may reported or not to the requesting phy-
sicians. It is also noteworthy that the EDTA tubes 
may be occasionally underfilled, so that the final 
concentration of K2EDTA would be much higher 
and the effect would be different, probably more 
significant.
One limitation of our study was that we did not 
evaluate the impact of contamination to with 
K2EDTA blood volumes lower than 5%, since the 
introduction of very small amounts of blood (i.e., 
lower than 50 µL), may lower the accuracy of dilu-
tion due to the intrinsic viscosity of whole blood. 
Moreover, the bias emerging from sample con-
tamination with small amounts of EDTA blood vol-
ume transferred by backflow during blood draw 
was previously tested by others, and the outcome 
was rather heterogeneous (3-6,8,9,27-30). It is also 
important to mention here that our results were 
generated using vacuum tubes from a single man-
ufacturer, so that they may not be directly trans-
ferable to other brands (31,32). Indeed, additional 
studies may be needed to define the impact of 
contamination with K2EDTA blood volumes lower 
than those that we have tested.
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The concentration of K2EDTA (i.e., from 0.09 to 0.77 
mg/mL) used in our experimental investigation 
(Table 1), is also commonplace in blood samples 
drawn from inpatients undergoing chelation ther-
apy. This treatment is based on multiple infusion 
(e.g., weekly) for the treatment of coronary and 
peripheral artery disease (33). Each chelation infu-
sion contains up to 3 g of EDTA (33). Therefore, in 
agreement with our data, the possibility that ED-
TA-based chelation treatment may interfere with 
laboratory testing should not be discounted.
Conclusion
In conclusion, the results of our investigation at-
test that concentration of calcium, magnesium, 
potassium, chloride and LD is dramatically biased 
by even a very modest K2EDTA contamination (i.e., 
0.09 mg/dL). The values of iron, phosphate, and 
sodium are still reliable up to 0.51 mg/dL K2EDTA 
contamination, whereas ALT, bilirubin, creatinine, 
and lipase appeared to be less significantly biased 
by K2EDTA contamination. This experimental in-
vestigation may hence provide general informa-
tion about the potential effect of K2EDTA blood 
contamination of lithium-heparin tubes, which 
may be useful to quality laboratory managers for 
establishing local policies for sample rejection 
and/or test results suppression.
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